This study is the first to elucidate the role of tetraspanins in TILs within the TME of patients with non-small cell carcinoma, following the observation of CD81 expression in the innate immune landscape of lung adenocarcinoma (47). The gene discussed is CD81; the disease is lung adenocarcinoma.